Month: December 2020

We’re targeting annualized yields of 43.9% to 72.5%.

Here are today’s upgrades and downgrades: AstraZeneca, Vornado, BioTelemetry and more.

Our target potential upside is 16% to 33% in the next 3-5 months.

The underlying stock has been in a downtrend since August and the daily stochastic indicators were in overbought territory as it made a bearish crossover last night.

Depending on your risk tolerance, here are two ways to trade it that could potentially return 20% to 63% in the next 3-6 months.